December 19, 2019
University of Virginia (UVA) Center for Diabetes Technology and Novo Nordisk today announced that they have entered into a five-year research collaboration where UVA and Novo Nordisk will work together on the development of virtual environments focused on modelling of patients with type 2 diabetes.
October 28, 2019
UVA Health has established a 16-person Advisory Council that will inform and advise UVA Health leaders as they consider additional improvements to billing and collection policies and practices to better meet the needs of patients.
October 17, 2019
Only 20% of an individual’s health status is related to clinical health care. The other 80% are shaped by socioeconomic factors, their physical environment, and their health behaviors. Having access to healthy foods, safe and stable housing, reliable transportation and a well-paying job leads to increased well-being. To better connect patients with community resources that can meet these needs, UVA Health purchased a technology-based referral network, PIECES Iris™.
October 16, 2019
A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.
September 25, 2019
The same approach that could prevent diabetes may also prove effective for battling autoimmune diseases such as lupus and eczema.
August 5, 2019
Four biomedical research projects to improve the health of Virginians will be funded by the integrated Translational Health Research Institute of Virginia (iTHRIV), a Clinical Translational Science Award Hub.
June 12, 2019
The integrated Translational Health Research Institute of Virginia (iTHRIV) has awarded funding to four multi-institutional research projects through the Pilot Translational and Clinical Studies Program. By providing seed grant funding to support early phase research projects, the program is intended to accelerate joint discovery and the application of translational medical research.